Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Reexamination Certificate
2007-05-08
2007-05-08
Kishore, Gollamudi S. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
C552S502000, C552S544000, C524S728000, C554S035000, C554S036000, C554S037000, C554S079000
Reexamination Certificate
active
10445642
ABSTRACT:
In accordance with the present invention, there are provided lipid-conjugated polyamide compounds and related compositions and methods thereof. Lipid-conjugated polyamide compounds of the present invention are particularly useful as vehicles for delivering biologically active agents to a target site. In particular, the invention compounds are effective at facilitating the delivery of polynucleotides to cells. The present invention also provides a method for producing stable formulations of polynucleotides complexed with a delivery vehicle.
REFERENCES:
patent: 5334761 (1994-08-01), Gebeyehu et al.
patent: 5395619 (1995-03-01), Zalipsky et al.
patent: 5534259 (1996-07-01), Zalipsky et al.
patent: 5595756 (1997-01-01), Bally et al.
patent: 5635487 (1997-06-01), Wolff et al.
patent: 5679559 (1997-10-01), Kim et al.
patent: 5705385 (1998-01-01), Bally et al.
patent: 6197332 (2001-03-01), Zuckermann et al.
patent: 6569450 (2003-05-01), Zuckermann et al.
patent: 6572881 (2003-06-01), Zuckermann et al.
patent: 545 016 (1992-09-01), None
patent: 544 292 (1993-06-01), None
patent: WO 91/19735 (1991-12-01), None
patent: WO 93/14778 (1993-08-01), None
patent: WO 94/06451 (1994-03-01), None
patent: WO 95/02391 (1995-01-01), None
patent: WO 95/28494 (1995-10-01), None
patent: WO 95/31557 (1995-11-01), None
patent: WO 96/04001 (1996-02-01), None
patent: WO 96/18372 (1996-06-01), None
patent: WO 96/22765 (1996-08-01), None
patent: WO 96/27379 (1996-09-01), None
patent: WO 97/11682 (1997-04-01), None
patent: WO 97/12052 (1997-04-01), None
patent: WO 97/45442 (1997-12-01), None
patent: WO 98/06437 (1998-02-01), None
patent: WO 98/27209 (1998-06-01), None
Aberle, A.M., et al., “A Novel Tetraester Construct that Reduces Cationic Lipid-Associated Cytotoxicity Implications for to Onset of Cytotoxicity”Biochemistry37:6533-6540(1998).
Batra, R.K., et al., “Receptor-Mediated Gene Delivery Employing Lectin-Binding Specificity”Gene Therapy1:255-260(1994).
Behr, J.P., et al., “Gene Transfer With Synthetic Cationic Amphiphiles: Prospects for Gene Therapy”Bioconjugate Chem.5:382-389 (1994).
Behr, J.P., et al., “The Proton Sponge: A Trick to Enter Cells the Viruses did not Exploit”CHIMIA51:34-36 (1997).
Crook, K., et al., “Inclusion of Cholesterol in DOTAP Transfection Complexes Increases the Delivery of DNA to Cells in Vitro in the Presence of Serum”Gene Therapy5:137-143 (1998).
Gao, X. and Huang, L., “Cationic Liposome-Mediated Gene Transfer”Gene Therapy2:710-722 (1995).
Gao, X. and Huang, L., “Potentiation of Cationic Liposome-Mediated Gene Transfer Delivery by Polycations”Biochemistry35:1027-1036 (1996).
Guy, J., et al., “Delivery of DNA into Mammalian Cells by Receptor-Mediated Endocytosis and Gene Therapy”Molecular Biotechnology3:237-248 (1995).
Hong, K., et al., “Stabilization of Cationic Liposome-Plasmid DNA Complexes by Polyamines and Poly (ethylene glycol)-phospholipid Conjugates for Efficient in vivo Gene Delivery”F E B S Letters400:233-237 (1997).
Kabanov, A.V. and Kabanov, V.A., “DNA Complexes with Polycations for the Delivery of Genetic Material into Cells”Bioconjugate Chem.6:7-20 (1995).
Lasic, D.D. and Templeton, N.S., “Liposomes in Gene Therapy”Advanced Drug Delivery Reviews20:221-226 (1996).
Ledley, F.D., “Nonviral gene therapy: the promise of genes as pharmaceutical products”Human Gene Ther.6:1129-1144 (1995).
Legendre, J.Y., et al., “Dioleoylmelittin as a Novel Serum-Insensitive Reagent for Efficient Transfection of Mammalian Cells”Bioconjugate Chem.8:57-63 (1997).
Liu, Y., et al., “Cationic Liposome-Mediated Intravenous Gene Delivery”J. Biological Chemistry270(42):24864-24870 (1995).
Mastrangelo, M.J., et al., “Gene therapy for human cancer: an essay for clinicians”Seminars in Oncology23(1):4-21 (1996).
Merwin, J.R., et al., “Targeted Delivery of DNA Using YEE(Ga1NAcAH)3, a Synthetic Glycopeptide Ligand for the Asialoglycoprotein Receptor”Bioconjugate Chemistry5(6):612-620 (1994).
Michael, S.I. and Curiel, D.T., “Strategies to Achieve Targeted Gene Delivery via the Receptor-Mediated Endocytosis Pathway”Gene Therapy1:223-232 (1994).
Ngo, et al., “Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox”The Protein Folding and Tertiary Structure Prediction,Mertz et al. (eds ) Birkhauser, Boston MA pp. 433 and 492-495 (1994).
Phillips, S.C., “Receptor-Mediated DNA Delivery Approaches to Human Gene Therapy”Biologicals23:13-16 (1995).
Remy, J.S., et al., “Targeted Gene Transfer into Hepatoma Cells With Lipopolyamine-Condensed DNA Particles Presenting Galactose Ligands: a Stage Toward Artificial Viruses”Proc. Natl. Acad. Sci.USA 92:1744-1748 (1995).
Richter,L.S. and Zuckermann, R.N., “Synthesis of Peptide Nucleic Acids (PNA) by Submonomer Solid-Phase Synthesis”Bioorganic and Medicinal Chemistry Letters5(11):1159-1162 (1995).
Tomlinson, E. and Rolland, A., “Controllable Gene Therapy Pharmaceutics of Non-Viral Gene Delivery Systems”J. Controlled Release39:357-372 (1996).
Wagner, E., et al., “DNA-Binding Transferrin Conjugates as Functional Gene-Delivery Agents: Synthesis by Linkage of Polylysine or Ethidium Homodimer to the Transferrin Carbohydrate moiety”Bioconjugate Chem.2(4):226-231 (1991).
Wagner, E., et al., “Influenza Virus Hemagglutinin HA-2 N-terminal Fusogenic Peptides Augment Gene Transfer by Transferrin-Polylysine-DNA Complexes: Toward a Synthetic Virus-like Gene-Transfer Vehicle”Proc. Natl. Acad. Sci.USA 89:7934-7938 (1992).
Wheeler, C.J., et al., “Converting an alcohol to an amine in a cationic lipid dramatically alters the co-lipid requirement, cellular transfection activity and the ultrastructure of DNA-cytofectin complexes”Biochim.et Biophsica Acta1280 1-11 (1996).
Yagi, Y., et al., “Interaction of poly N-(3-aminopropyl)glycine! and its derivatives with lipid membrane”Bull Chem Soc Jpn61(11):3983-3989 (1988).
Zhou, X., et al., “DNA Trasnfecion Mediated by Cationic Liposomes Containing Lipopolylysine: Characterization and Mechanism of Action” Biochimica et Biophysica Acta 1189:195-203 (1994).
Huang Chin-Yi
Murphy John E.
Uno Tetsuo
Zuckermann Ronald N.
Austin James E.
Harbin Alisa A.
Kishore Gollamudi S.
Lillis Marcella
Novartis Vaccines And Diagnostics, Inc.
LandOfFree
Lipid-conjugated polyamide compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lipid-conjugated polyamide compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipid-conjugated polyamide compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3767248